The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Dupixent Shortage: What Providers and Prescribers Need to Know in 2026
Dupixent access challenges in 2026 affect thousands of patients. Here's what prescribers need to know about prior auth, step therapy, and biosimilar timelines.
Eletriptan Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on eletriptan availability, insurance barriers, patient access challenges, and prescribing strategies in 2026.
Eplerenone Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on Eplerenone supply and access challenges in 2026 — including formulary obstacles, cost barriers, and tools to keep patients on guideline-directed therapy.
Estratest Shortage: What Providers and Prescribers Need to Know in 2026
A clinical overview of Estratest (EEMT) availability challenges in 2026: supply drivers, regulatory considerations, and practical guidance for prescribers managing affected patients.
31,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.
Etanercept Shortage: What Providers and Prescribers Need to Know in 2026
Etanercept access is increasingly complex for patients in 2026. This provider guide covers the key barriers, prior auth strategies, and how to support continuity of care.
Ethinyl Estradiol/Levonorgestrel Shortage: What Providers and Prescribers Need to Know in 2026
No national FDA shortage exists for ethinyl estradiol/levonorgestrel, but your patients are still struggling to fill prescriptions. Here's what providers need to know in 2026.
Fluconazole Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on fluconazole availability in 2026: FDA shortage status, resistance trends, formulary considerations, and patient counseling strategies.
Forteo Shortage: What Providers and Prescribers Need to Know in 2026
Forteo is not in an official shortage in 2026, but specialty distribution and insurance barriers affect real-world access. A clinical briefing for prescribers.
Griseofulvin Shortage: What Providers and Prescribers Need to Know in 2026
Griseofulvin isn't in an official FDA shortage, but availability gaps — especially for the oral suspension — create real challenges for patients. Here's what prescribers need to know in 2026.
Humalog Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers navigating the Humalog (insulin lispro) shortage in 2026 — including therapeutic alternatives, dose conversions, patient communication, and access resources.
Humulin N Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for providers on Humulin N availability in 2026: current shortage status, therapeutic alternatives, patient communication strategies, and proactive prescribing recommendations.
Hycamtin Shortage: What Providers and Prescribers Need to Know in 2026
A clinical guide for oncologists and prescribers navigating Hycamtin (topotecan) availability challenges in 2026, including sourcing strategies and therapeutic alternatives.